Back
Johnson Outdoors Vs. Janux Therapeutics Industry Stock Comparison
Sell
22
JOUT
Johnson Outdoors
Last Price:
$34.45
Seasonality Move:
7.76%
Sell
29
JANX
Janux Therapeutics
Last Price:
$53.95
Seasonality Move:
84.76%
Sell
22
Johnson Outdoors (JOUT)
is a Sell
Is Johnson Outdoors a Buy, Sell or Hold?
-
The current Johnson Outdoors [JOUT] share price is $34.80. The Score for JOUT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
JOUT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
-
The current Janux Therapeutics [JANX] share price is $55.17. The Score for JANX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JOUT Stock Price Chart
What is Johnson Outdoors's stock price today?
-
The Johnson Outdoors share price today is $34.80The current trend is moderately bearish and JOUT is experiencing buying pressure, which is a positive indicator for future bullish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $55.17Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing slight selling pressure.
JOUT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 49.07 | Sell |
Chaikin Money Flow: | 34646 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.94 - 36.42) | Buy |
Bollinger Bands (100): | (33.28 - 36.58) | Sell |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.93 | Buy |
Relative Strength Index (14 RSI): | 47.52 | Sell |
Chaikin Money Flow: | -44683 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.81 - 63.21) | Sell |
Bollinger Bands (100): | (42.47 - 56.33) | Buy |
JOUT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.1 | Sell |
20-day SMA: | 35.12 | Sell |
50-day SMA: | 33.96 | Buy |
200-day SMA: | 37.04 | Sell |
8-day EMA: | 35.54 | Sell |
20-day EMA: | 35.22 | Sell |
50-day EMA: | 34.73 | Buy |
200-day EMA: | 37.96 | Sell |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.23 | Sell |
20-day SMA: | 57.88 | Sell |
50-day SMA: | 54.34 | Buy |
200-day SMA: | 47.11 | Buy |
8-day EMA: | 57.05 | Sell |
20-day EMA: | 56.98 | Sell |
50-day EMA: | 54.29 | Buy |
200-day EMA: | 44.48 | Buy |
Johnson Outdoors Earnings Growth & JOUT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.02 per share, and an increase next year of $0.40 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.97 per share.
Johnson Outdoors Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |